Get started
BBB

Celgene Corporation 5.25% 15-AUG-2043

No trades
See on Supercharts
Overview
Analysis

BMY4036425 chart


Full chart

Key terms


Outstanding amount
‪4.06 M‬ USD
Face value
1,000.00 USD
Minimum denomination
2,000.00 USD
Coupon
5.25% (Fixed)
Coupon frequency
Semi-annual
Yield to maturity
7.52%
Maturity date
Aug 15, 2043
Term to maturity
18 years

About Celgene Corporation 5.25% 15-AUG-2043


Issuer
Celgene Corp.
Sector
Health Technology
Industry
Biotechnology
Home page
bms.com
Issue date
Aug 6, 2013
FIGI
BBG004XMK9R5
Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.

BMY4036425 analysis


Advanced bond data for paid plans
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.

Dive into corporate with bonds that match in maturity and industry.